3D Medicines, Inc. (HK:1244) has released an update.
In a voluntary move, 3D Medicines Inc.’s founder and executive team have recently increased their holdings, with founder Dr. Gong Zhaolong purchasing 20,000 shares, and senior management acquiring up to 22,000 shares on the open market. They have also announced a Share Purchase Plan to buy up to 1 million ordinary shares within the next 12 months, signaling strong confidence in the company’s future growth and stability. The company also confirmed maintaining sufficient public float of shares following these transactions.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.